Fatih Can Karaca1, Tuncay Taş2. 1. Department of Health Sciences, Bilgi University, Istanbul, Turkey. drckaraca@yahoo.com. 2. Vocational School of Health Sciences, Nişantaşı University, Istanbul, Turkey.
Abstract
PURPOSE: Majority of men with type 2 diabetes mellitus (T2DM) have been reported to experience erectile dysfunction (ED) in a lifetime. The aim of our study was to prospectively evaluate the postoperative condition of ED and premature ejaculation (PE) in men who underwent metabolic surgery for the treatment of T2DM. MATERIALS AND METHODS: A total of 36 sexually active male individuals with T2DM who were applied for metabolic surgery were given two different questionnaire forms prior to and 6 months after the surgery. Patients filled the International Index of Erectile Function (IIEF) and the Premature Ejaculation Profile (PEP) questionnaires before and 6 months after the surgery. The BMI, fasting blood glucose (FBG), and glycated hemoglobin (HbA1c) concentrations were also measured prior to the surgery and on follow-up points of postoperative first, third, and sixth months. RESULTS: Erectile function (EF) and overall satisfaction domains of the IIEF questionnaire increased significantly after the surgery in the patient groups irrespective of the previous ED severity (p < 0.001). There were significant improvements of the PEP interpersonal difficulty related to ejaculation score and HbA1c levels in the severe/moderate EF group and IIEF EF, PEP interpersonal difficulty related to ejaculation domains, and HbA1c levels of mild to moderate/mild/no ED group after the metabolic surgery. CONCLUSION: Metabolic surgery could improve erectile and ejaculatory function scores of obese patients with T2DM.
PURPOSE: Majority of men with type 2 diabetes mellitus (T2DM) have been reported to experience erectile dysfunction (ED) in a lifetime. The aim of our study was to prospectively evaluate the postoperative condition of ED and premature ejaculation (PE) in men who underwent metabolic surgery for the treatment of T2DM. MATERIALS AND METHODS: A total of 36 sexually active male individuals with T2DM who were applied for metabolic surgery were given two different questionnaire forms prior to and 6 months after the surgery. Patients filled the International Index of Erectile Function (IIEF) and the Premature Ejaculation Profile (PEP) questionnaires before and 6 months after the surgery. The BMI, fasting blood glucose (FBG), and glycated hemoglobin (HbA1c) concentrations were also measured prior to the surgery and on follow-up points of postoperative first, third, and sixth months. RESULTS: Erectile function (EF) and overall satisfaction domains of the IIEF questionnaire increased significantly after the surgery in the patient groups irrespective of the previous ED severity (p < 0.001). There were significant improvements of the PEP interpersonal difficulty related to ejaculation score and HbA1c levels in the severe/moderate EF group and IIEF EF, PEP interpersonal difficulty related to ejaculation domains, and HbA1c levels of mild to moderate/mild/no ED group after the metabolic surgery. CONCLUSION: Metabolic surgery could improve erectile and ejaculatory function scores of obesepatients with T2DM.
Authors: Maha Aleid; Asif Muneer; Sara Renshaw; Jason George; Andrew D Jenkinson; Marco Adamo; Mohamed Elkalaawy; Rachel L Batterham; David J Ralph; Majid Hashemi; Selim Cellek Journal: J Sex Med Date: 2017-01-10 Impact factor: 3.802
Authors: Ronald W Lewis; Kerstin S Fugl-Meyer; Giovanni Corona; Richard D Hayes; Edward O Laumann; Edson D Moreira; Alessandra H Rellini; Taylor Segraves Journal: J Sex Med Date: 2010-04 Impact factor: 3.802
Authors: Francesco Rubino; David M Nathan; Robert H Eckel; Philip R Schauer; K George M M Alberti; Paul Z Zimmet; Stefano Del Prato; Linong Ji; Shaukat M Sadikot; William H Herman; Stephanie A Amiel; Lee M Kaplan; Gaspar Taroncher-Oldenburg; David E Cummings Journal: Diabetes Care Date: 2016-06 Impact factor: 19.112
Authors: Christina Wang; Graham Jackson; T Hugh Jones; Alvin M Matsumoto; Ajay Nehra; Michael A Perelman; Ronald S Swerdloff; Abdul Traish; Michael Zitzmann; Glenn Cunningham Journal: Diabetes Care Date: 2011-07 Impact factor: 19.112